483 Shandong Anhong Pharmaceutical Oct 2020

483 Shandong Anhong Pharmaceutical Oct 2020

Jonathan Chapman FDA$119.00 - Available Now

FDA investigators audited the Shandong Anhong Pharmaceutical - Dezhou, China facility and issued inspectional observations (via FDA 483) on 30 Oct 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Oct 2020
  • Location: Dezhou, China
  • FEI: 3003877289
Add To Cart